MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien (MKGAF) Stock Competitors & Peer Comparison
See (MKGAF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MKGAF | $124.51 | -0.43% | 54.1B | 15.96 | $7.80 | +2.01% |
| IPSEY | $43.09 | -3.45% | 57B | 28.16 | $1.53 | +0.93% |
| TKPHF | $34.05 | -5.57% | 53.8B | 77.39 | $0.44 | +3.88% |
| MKKGY | $23.97 | +0.29% | 52.1B | 15.37 | $1.56 | +2.09% |
| HLNCF | $4.81 | -2.53% | 42.8B | 19.24 | $0.25 | +1.92% |
| SDZNY | $75.94 | -0.83% | 32.8B | 36.25 | $2.09 | +0.96% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $21.45 | +19.17% | 18.3B | 17.02 | $1.26 | +2.06% |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
| SGIOY | $10.46 | +0.29% | 17.8B | 16.64 | $0.63 | +1.92% |
Stock Comparison
MKGAF vs IPSEY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, IPSEY has a market cap of 57B. Regarding current trading prices, MKGAF is priced at $124.51, while IPSEY trades at $43.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas IPSEY's P/E ratio is 28.16. In terms of profitability, MKGAF's ROE is +0.09%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, MKGAF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check IPSEY's competition here
MKGAF vs TKPHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, TKPHF has a market cap of 53.8B. Regarding current trading prices, MKGAF is priced at $124.51, while TKPHF trades at $34.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas TKPHF's P/E ratio is 77.39. In terms of profitability, MKGAF's ROE is +0.09%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, MKGAF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check TKPHF's competition here
MKGAF vs MKKGY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, MKKGY has a market cap of 52.1B. Regarding current trading prices, MKGAF is priced at $124.51, while MKKGY trades at $23.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas MKKGY's P/E ratio is 15.37. In terms of profitability, MKGAF's ROE is +0.09%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, MKGAF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check MKKGY's competition here
MKGAF vs HLNCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HLNCF has a market cap of 42.8B. Regarding current trading prices, MKGAF is priced at $124.51, while HLNCF trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HLNCF's P/E ratio is 19.24. In terms of profitability, MKGAF's ROE is +0.09%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, MKGAF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check HLNCF's competition here
MKGAF vs SDZNY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SDZNY has a market cap of 32.8B. Regarding current trading prices, MKGAF is priced at $124.51, while SDZNY trades at $75.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SDZNY's P/E ratio is 36.25. In terms of profitability, MKGAF's ROE is +0.09%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, MKGAF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check SDZNY's competition here
MKGAF vs TEVJF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, MKGAF is priced at $124.51, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, MKGAF's ROE is +0.09%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, MKGAF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check TEVJF's competition here
MKGAF vs SGIOF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SGIOF has a market cap of 18.3B. Regarding current trading prices, MKGAF is priced at $124.51, while SGIOF trades at $21.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SGIOF's P/E ratio is 17.02. In terms of profitability, MKGAF's ROE is +0.09%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, MKGAF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check SGIOF's competition here
MKGAF vs TAIPY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, MKGAF is priced at $124.51, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, MKGAF's ROE is +0.09%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, MKGAF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check TAIPY's competition here
MKGAF vs SGIOY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SGIOY has a market cap of 17.8B. Regarding current trading prices, MKGAF is priced at $124.51, while SGIOY trades at $10.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SGIOY's P/E ratio is 16.64. In terms of profitability, MKGAF's ROE is +0.09%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, MKGAF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check SGIOY's competition here
MKGAF vs ESALY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, MKGAF is priced at $124.51, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ESALY's P/E ratio is 20.54. In terms of profitability, MKGAF's ROE is +0.09%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, MKGAF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check ESALY's competition here
MKGAF vs BIOVF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, BIOVF has a market cap of 14.3B. Regarding current trading prices, MKGAF is priced at $124.51, while BIOVF trades at $41.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas BIOVF's P/E ratio is 295.14. In terms of profitability, MKGAF's ROE is +0.09%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, MKGAF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check BIOVF's competition here
MKGAF vs IPSEF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, MKGAF is priced at $124.51, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, MKGAF's ROE is +0.09%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, MKGAF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check IPSEF's competition here
MKGAF vs ESAIY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ESAIY has a market cap of 8.6B. Regarding current trading prices, MKGAF is priced at $124.51, while ESAIY trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ESAIY's P/E ratio is 28.07. In terms of profitability, MKGAF's ROE is +0.09%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, MKGAF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check ESAIY's competition here
MKGAF vs ESALF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ESALF has a market cap of 8.6B. Regarding current trading prices, MKGAF is priced at $124.51, while ESALF trades at $30.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ESALF's P/E ratio is 27.82. In terms of profitability, MKGAF's ROE is +0.09%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, MKGAF is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check ESALF's competition here
MKGAF vs SFOSF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SFOSF has a market cap of 6.5B. Regarding current trading prices, MKGAF is priced at $124.51, while SFOSF trades at $2.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SFOSF's P/E ratio is 13.53. In terms of profitability, MKGAF's ROE is +0.09%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, MKGAF is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check SFOSF's competition here
MKGAF vs LVZPF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, MKGAF is priced at $124.51, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, MKGAF's ROE is +0.09%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, MKGAF is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check LVZPF's competition here
MKGAF vs GZPHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, MKGAF is priced at $124.51, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, MKGAF's ROE is +0.09%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, MKGAF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check GZPHF's competition here
MKGAF vs DNPUF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, DNPUF has a market cap of 5.3B. Regarding current trading prices, MKGAF is priced at $124.51, while DNPUF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas DNPUF's P/E ratio is 5.45. In terms of profitability, MKGAF's ROE is +0.09%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, MKGAF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check DNPUF's competition here
MKGAF vs SMDPY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SMDPY has a market cap of 4.8B. Regarding current trading prices, MKGAF is priced at $124.51, while SMDPY trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SMDPY's P/E ratio is 4.95. In terms of profitability, MKGAF's ROE is +0.09%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, MKGAF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check SMDPY's competition here
MKGAF vs HLUBF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, MKGAF is priced at $124.51, while HLUBF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HLUBF's P/E ratio is 9.84. In terms of profitability, MKGAF's ROE is +0.09%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, MKGAF is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check HLUBF's competition here
MKGAF vs HLBBF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HLBBF has a market cap of 4.5B. Regarding current trading prices, MKGAF is priced at $124.51, while HLBBF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HLBBF's P/E ratio is 11.18. In terms of profitability, MKGAF's ROE is +0.09%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, MKGAF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check HLBBF's competition here
MKGAF vs SGFEF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, MKGAF is priced at $124.51, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SGFEF's P/E ratio is 20.66. In terms of profitability, MKGAF's ROE is +0.09%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, MKGAF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check SGFEF's competition here
MKGAF vs HKMPF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HKMPF has a market cap of 3.8B. Regarding current trading prices, MKGAF is priced at $124.51, while HKMPF trades at $17.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HKMPF's P/E ratio is 9.56. In terms of profitability, MKGAF's ROE is +0.09%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, MKGAF is less volatile compared to HKMPF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check HKMPF's competition here
MKGAF vs APNHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, MKGAF is priced at $124.51, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas APNHF's P/E ratio is -34.17. In terms of profitability, MKGAF's ROE is +0.09%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, MKGAF is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check APNHF's competition here
MKGAF vs HKMPY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HKMPY has a market cap of 3.6B. Regarding current trading prices, MKGAF is priced at $124.51, while HKMPY trades at $33.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HKMPY's P/E ratio is 9.13. In terms of profitability, MKGAF's ROE is +0.09%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, MKGAF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check HKMPY's competition here
MKGAF vs ULIHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, MKGAF is priced at $124.51, while ULIHF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ULIHF's P/E ratio is 7.08. In terms of profitability, MKGAF's ROE is +0.09%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, MKGAF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check ULIHF's competition here
MKGAF vs APNHY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, APNHY has a market cap of 3.3B. Regarding current trading prices, MKGAF is priced at $124.51, while APNHY trades at $7.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas APNHY's P/E ratio is -31.17. In terms of profitability, MKGAF's ROE is +0.09%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, MKGAF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check APNHY's competition here
MKGAF vs LBTSF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, MKGAF is priced at $124.51, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas LBTSF's P/E ratio is 61.40. In terms of profitability, MKGAF's ROE is +0.09%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, MKGAF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check LBTSF's competition here
MKGAF vs CHSYF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, MKGAF is priced at $124.51, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, MKGAF's ROE is +0.09%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, MKGAF is less volatile compared to CHSYF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check CHSYF's competition here
MKGAF vs HYPMY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HYPMY has a market cap of 3.2B. Regarding current trading prices, MKGAF is priced at $124.51, while HYPMY trades at $4.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HYPMY's P/E ratio is 12.53. In terms of profitability, MKGAF's ROE is +0.09%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, MKGAF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check HYPMY's competition here
MKGAF vs INVVY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, MKGAF is priced at $124.51, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas INVVY's P/E ratio is -62.42. In terms of profitability, MKGAF's ROE is +0.09%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, MKGAF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check INVVY's competition here
MKGAF vs IZQVF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, MKGAF is priced at $124.51, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, MKGAF's ROE is +0.09%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, MKGAF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check IZQVF's competition here
MKGAF vs HMDCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, MKGAF is priced at $124.51, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, MKGAF's ROE is +0.09%, compared to HMDCF's ROE of +0.42%. Regarding short-term risk, MKGAF is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check HMDCF's competition here
MKGAF vs NPPNY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, MKGAF is priced at $124.51, while NPPNY trades at $8.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas NPPNY's P/E ratio is 11.65. In terms of profitability, MKGAF's ROE is +0.09%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, MKGAF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check NPPNY's competition here
MKGAF vs NPNKF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, MKGAF is priced at $124.51, while NPNKF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas NPNKF's P/E ratio is 10.77. In terms of profitability, MKGAF's ROE is +0.09%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, MKGAF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check NPNKF's competition here
MKGAF vs DMPHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, MKGAF is priced at $124.51, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, MKGAF's ROE is +0.09%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, MKGAF is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check DMPHF's competition here
MKGAF vs HTSUF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, MKGAF is priced at $124.51, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, MKGAF's ROE is +0.09%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, MKGAF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check HTSUF's competition here
MKGAF vs ARSUF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, MKGAF is priced at $124.51, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ARSUF's P/E ratio is 18.75. In terms of profitability, MKGAF's ROE is +0.09%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, MKGAF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check ARSUF's competition here
MKGAF vs DUTV Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, MKGAF is priced at $124.51, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas DUTV's P/E ratio is N/A. In terms of profitability, MKGAF's ROE is +0.09%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, MKGAF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check DUTV's competition here
MKGAF vs CURLF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CURLF has a market cap of 1.8B. Regarding current trading prices, MKGAF is priced at $124.51, while CURLF trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CURLF's P/E ratio is -7.09. In terms of profitability, MKGAF's ROE is +0.09%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, MKGAF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check CURLF's competition here
MKGAF vs TSMRF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, MKGAF is priced at $124.51, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, MKGAF's ROE is +0.09%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, MKGAF is less volatile compared to TSMRF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check TSMRF's competition here
MKGAF vs SHPHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, MKGAF is priced at $124.51, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, MKGAF's ROE is +0.09%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, MKGAF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check SHPHF's competition here
MKGAF vs MITPF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, MKGAF is priced at $124.51, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas MITPF's P/E ratio is -10.81. In terms of profitability, MKGAF's ROE is +0.09%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, MKGAF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check MITPF's competition here
MKGAF vs GTBIF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, MKGAF is priced at $124.51, while GTBIF trades at $6.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas GTBIF's P/E ratio is 13.67. In terms of profitability, MKGAF's ROE is +0.09%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, MKGAF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check GTBIF's competition here
MKGAF vs KARBF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, MKGAF is priced at $124.51, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas KARBF's P/E ratio is 262.50. In terms of profitability, MKGAF's ROE is +0.09%, compared to KARBF's ROE of N/A. Regarding short-term risk, MKGAF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check KARBF's competition here
MKGAF vs CHIZF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, MKGAF is priced at $124.51, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, MKGAF's ROE is +0.09%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, MKGAF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check CHIZF's competition here
MKGAF vs CASBF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, MKGAF is priced at $124.51, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CASBF's P/E ratio is -38.60. In terms of profitability, MKGAF's ROE is +0.09%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, MKGAF is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check CASBF's competition here
MKGAF vs SWGHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, MKGAF is priced at $124.51, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, MKGAF's ROE is +0.09%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, MKGAF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check SWGHF's competition here
MKGAF vs TCNNF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, MKGAF is priced at $124.51, while TCNNF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas TCNNF's P/E ratio is -10.78. In terms of profitability, MKGAF's ROE is +0.09%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, MKGAF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check TCNNF's competition here
MKGAF vs LJUIF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, MKGAF is priced at $124.51, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, MKGAF's ROE is +0.09%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, MKGAF is less volatile compared to LJUIF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check LJUIF's competition here
MKGAF vs BIOGY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, MKGAF is priced at $124.51, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, MKGAF's ROE is +0.09%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, MKGAF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check BIOGY's competition here
MKGAF vs KSPHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, MKGAF is priced at $124.51, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas KSPHF's P/E ratio is 11.99. In terms of profitability, MKGAF's ROE is +0.09%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, MKGAF is less volatile compared to KSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check KSPHF's competition here
MKGAF vs KKPCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, MKGAF is priced at $124.51, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, MKGAF's ROE is +0.09%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, MKGAF is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check KKPCF's competition here
MKGAF vs GNMLF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, GNMLF has a market cap of 973.8M. Regarding current trading prices, MKGAF is priced at $124.51, while GNMLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas GNMLF's P/E ratio is 11.11. In terms of profitability, MKGAF's ROE is +0.09%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, MKGAF and GNMLF have similar daily volatility (5.13).Check GNMLF's competition here
MKGAF vs EVOTF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, EVOTF has a market cap of 931.2M. Regarding current trading prices, MKGAF is priced at $124.51, while EVOTF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas EVOTF's P/E ratio is -5.04. In terms of profitability, MKGAF's ROE is +0.09%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, MKGAF is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check EVOTF's competition here
MKGAF vs TWAPF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, MKGAF is priced at $124.51, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, MKGAF's ROE is +0.09%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, MKGAF is less volatile compared to TWAPF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check TWAPF's competition here
MKGAF vs NIKA Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, MKGAF is priced at $124.51, while NIKA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas NIKA's P/E ratio is N/A. In terms of profitability, MKGAF's ROE is +0.09%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, MKGAF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check NIKA's competition here
MKGAF vs CSWYF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, MKGAF is priced at $124.51, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, MKGAF's ROE is +0.09%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, MKGAF is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check CSWYF's competition here
MKGAF vs TRXPF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, MKGAF is priced at $124.51, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, MKGAF's ROE is +0.09%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, MKGAF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check TRXPF's competition here
MKGAF vs SHEZF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, MKGAF is priced at $124.51, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, MKGAF's ROE is +0.09%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, MKGAF is less volatile compared to SHEZF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check SHEZF's competition here
MKGAF vs YIHCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, MKGAF is priced at $124.51, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, MKGAF's ROE is +0.09%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, MKGAF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check YIHCF's competition here
MKGAF vs AIHLF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, MKGAF is priced at $124.51, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, MKGAF's ROE is +0.09%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, MKGAF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check AIHLF's competition here
MKGAF vs TRSSF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, MKGAF is priced at $124.51, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, MKGAF's ROE is +0.09%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, MKGAF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check TRSSF's competition here
MKGAF vs GLASF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, GLASF has a market cap of 582M. Regarding current trading prices, MKGAF is priced at $124.51, while GLASF trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas GLASF's P/E ratio is -35.86. In terms of profitability, MKGAF's ROE is +0.09%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, MKGAF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check GLASF's competition here
MKGAF vs PKBFF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, MKGAF is priced at $124.51, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas PKBFF's P/E ratio is N/A. In terms of profitability, MKGAF's ROE is +0.09%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, MKGAF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check PKBFF's competition here
MKGAF vs CCHWF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, MKGAF is priced at $124.51, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, MKGAF's ROE is +0.09%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, MKGAF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check CCHWF's competition here
MKGAF vs BOIRF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, MKGAF is priced at $124.51, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, MKGAF's ROE is +0.09%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, MKGAF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check BOIRF's competition here
MKGAF vs AGYTF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, MKGAF is priced at $124.51, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, MKGAF's ROE is +0.09%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, MKGAF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check AGYTF's competition here
MKGAF vs KHTRF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, KHTRF has a market cap of 498.1M. Regarding current trading prices, MKGAF is priced at $124.51, while KHTRF trades at $5.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas KHTRF's P/E ratio is -127.01. In terms of profitability, MKGAF's ROE is +0.09%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, MKGAF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check KHTRF's competition here
MKGAF vs PEXXF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, MKGAF is priced at $124.51, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, MKGAF's ROE is +0.09%, compared to PEXXF's ROE of N/A. Regarding short-term risk, MKGAF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check PEXXF's competition here
MKGAF vs SWDCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SWDCF has a market cap of 439.2M. Regarding current trading prices, MKGAF is priced at $124.51, while SWDCF trades at $2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SWDCF's P/E ratio is 68.69. In terms of profitability, MKGAF's ROE is +0.09%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, MKGAF is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check SWDCF's competition here
MKGAF vs VRNOF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, VRNOF has a market cap of 434.2M. Regarding current trading prices, MKGAF is priced at $124.51, while VRNOF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas VRNOF's P/E ratio is -1.21. In terms of profitability, MKGAF's ROE is +0.09%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, MKGAF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check VRNOF's competition here
MKGAF vs HUMDF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HUMDF has a market cap of 407.7M. Regarding current trading prices, MKGAF is priced at $124.51, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HUMDF's P/E ratio is 2.58. In terms of profitability, MKGAF's ROE is +0.09%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, MKGAF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check HUMDF's competition here
MKGAF vs ELTP Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ELTP has a market cap of 399.6M. Regarding current trading prices, MKGAF is priced at $124.51, while ELTP trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ELTP's P/E ratio is 9.28. In terms of profitability, MKGAF's ROE is +0.09%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, MKGAF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check ELTP's competition here
MKGAF vs CRLBF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CRLBF has a market cap of 340.8M. Regarding current trading prices, MKGAF is priced at $124.51, while CRLBF trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CRLBF's P/E ratio is -2.61. In terms of profitability, MKGAF's ROE is +0.09%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, MKGAF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check CRLBF's competition here
MKGAF vs CPHRF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CPHRF has a market cap of 305.5M. Regarding current trading prices, MKGAF is priced at $124.51, while CPHRF trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CPHRF's P/E ratio is 11.47. In terms of profitability, MKGAF's ROE is +0.09%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, MKGAF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check CPHRF's competition here
MKGAF vs BHCCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, MKGAF is priced at $124.51, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, MKGAF's ROE is +0.09%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, MKGAF is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check BHCCF's competition here
MKGAF vs PLNHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, MKGAF is priced at $124.51, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, MKGAF's ROE is +0.09%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, MKGAF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check PLNHF's competition here
MKGAF vs PHCUF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, MKGAF is priced at $124.51, while PHCUF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, MKGAF's ROE is +0.09%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, MKGAF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check PHCUF's competition here
MKGAF vs SHIEF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, MKGAF is priced at $124.51, while SHIEF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, MKGAF's ROE is +0.09%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, MKGAF is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check SHIEF's competition here
MKGAF vs COPHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, MKGAF is priced at $124.51, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas COPHF's P/E ratio is -0.02. In terms of profitability, MKGAF's ROE is +0.09%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, MKGAF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check COPHF's competition here
MKGAF vs CBWTF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CBWTF has a market cap of 130.8M. Regarding current trading prices, MKGAF is priced at $124.51, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CBWTF's P/E ratio is 3.23. In terms of profitability, MKGAF's ROE is +0.09%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, MKGAF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check CBWTF's competition here
MKGAF vs LOVFF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, LOVFF has a market cap of 129.9M. Regarding current trading prices, MKGAF is priced at $124.51, while LOVFF trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas LOVFF's P/E ratio is 15.07. In terms of profitability, MKGAF's ROE is +0.09%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, MKGAF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check LOVFF's competition here
MKGAF vs NWPN Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, MKGAF is priced at $124.51, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas NWPN's P/E ratio is -0.04. In terms of profitability, MKGAF's ROE is +0.09%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, MKGAF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check NWPN's competition here
MKGAF vs BIOYF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, BIOYF has a market cap of 121.2M. Regarding current trading prices, MKGAF is priced at $124.51, while BIOYF trades at $10.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas BIOYF's P/E ratio is 19.20. In terms of profitability, MKGAF's ROE is +0.09%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, MKGAF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check BIOYF's competition here
MKGAF vs LPCUF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, MKGAF is priced at $124.51, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, MKGAF's ROE is +0.09%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, MKGAF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check LPCUF's competition here
MKGAF vs CWBHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CWBHF has a market cap of 110M. Regarding current trading prices, MKGAF is priced at $124.51, while CWBHF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CWBHF's P/E ratio is -4.93. In terms of profitability, MKGAF's ROE is +0.09%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, MKGAF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check CWBHF's competition here
MKGAF vs CNVCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, MKGAF is priced at $124.51, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, MKGAF's ROE is +0.09%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, MKGAF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check CNVCF's competition here
MKGAF vs AAWH Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, AAWH has a market cap of 101.3M. Regarding current trading prices, MKGAF is priced at $124.51, while AAWH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas AAWH's P/E ratio is -0.86. In terms of profitability, MKGAF's ROE is +0.09%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, MKGAF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check AAWH's competition here
MKGAF vs ORXOY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ORXOY has a market cap of 97.2M. Regarding current trading prices, MKGAF is priced at $124.51, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ORXOY's P/E ratio is -2.26. In terms of profitability, MKGAF's ROE is +0.09%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, MKGAF is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check ORXOY's competition here
MKGAF vs ABSCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, MKGAF is priced at $124.51, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ABSCF's P/E ratio is -8.53. In terms of profitability, MKGAF's ROE is +0.09%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, MKGAF is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check ABSCF's competition here
MKGAF vs HLTRF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, HLTRF has a market cap of 93.8M. Regarding current trading prices, MKGAF is priced at $124.51, while HLTRF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas HLTRF's P/E ratio is -7.69. In terms of profitability, MKGAF's ROE is +0.09%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, MKGAF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check HLTRF's competition here
MKGAF vs JUSHF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, JUSHF has a market cap of 90.8M. Regarding current trading prices, MKGAF is priced at $124.51, while JUSHF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas JUSHF's P/E ratio is -1.40. In terms of profitability, MKGAF's ROE is +0.09%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, MKGAF is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check JUSHF's competition here
MKGAF vs ORXOF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, ORXOF has a market cap of 79.3M. Regarding current trading prices, MKGAF is priced at $124.51, while ORXOF trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas ORXOF's P/E ratio is -1.84. In terms of profitability, MKGAF's ROE is +0.09%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, MKGAF is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for MKGAF.Check ORXOF's competition here
MKGAF vs GRUSF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, GRUSF has a market cap of 77.4M. Regarding current trading prices, MKGAF is priced at $124.51, while GRUSF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas GRUSF's P/E ratio is 10.33. In terms of profitability, MKGAF's ROE is +0.09%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, MKGAF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check GRUSF's competition here
MKGAF vs PROCF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, PROCF has a market cap of 75M. Regarding current trading prices, MKGAF is priced at $124.51, while PROCF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas PROCF's P/E ratio is 0.08. In terms of profitability, MKGAF's ROE is +0.09%, compared to PROCF's ROE of -2.24%. Regarding short-term risk, MKGAF is more volatile compared to PROCF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check PROCF's competition here
MKGAF vs MEDXF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, MEDXF has a market cap of 74.3M. Regarding current trading prices, MKGAF is priced at $124.51, while MEDXF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas MEDXF's P/E ratio is -115.00. In terms of profitability, MKGAF's ROE is +0.09%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, MKGAF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check MEDXF's competition here
MKGAF vs EOFBY Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, MKGAF is priced at $124.51, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, MKGAF's ROE is +0.09%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, MKGAF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check EOFBY's competition here
MKGAF vs GDNSF Comparison March 2026
MKGAF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MKGAF stands at 54.1B. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, MKGAF is priced at $124.51, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MKGAF currently has a P/E ratio of 15.96, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, MKGAF's ROE is +0.09%, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, MKGAF is more volatile compared to GDNSF. This indicates potentially higher risk in terms of short-term price fluctuations for MKGAF.Check GDNSF's competition here